Cargando…
A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix
Nonalcoholic fatty liver disease, a type of metabolic syndrome, continues to rise globally. Currently, there is no approved drug for its treatment. Improving lifestyle and exercise can alleviate symptoms, but patients' compliance is poor. More and more studies have shown the potential of Polygo...
Autores principales: | Zhou, Mengting, Hu, Naihua, Liu, Meichen, Deng, Ying, He, Linfeng, Guo, Chaocheng, Zhao, Xingtao, Li, Yunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193283/ https://www.ncbi.nlm.nih.gov/pubmed/32382557 http://dx.doi.org/10.1155/2020/5462063 |
Ejemplares similares
-
Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids
por: Dai, Xuyang, et al.
Publicado: (2021) -
Overview of Pharmacokinetics and Liver Toxicities of Radix Polygoni Multiflori
por: Li, Dan, et al.
Publicado: (2020) -
Metabolomics profiling of Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata extracts using UPLC-Q/TOF-MS
por: Zhang, Zhaoyan, et al.
Publicado: (2019) -
Influence Factors on the Hepatotoxicity of Polygoni Multiflori Radix
por: Wei, Yun, et al.
Publicado: (2019) -
Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway
por: Yu, Linyuan, et al.
Publicado: (2020)